Cell type-specific efferocytosis determines functional plasticity of alveolar macrophages.
Cell type-specific efferocytosis determines functional plasticity of alveolar macrophages. Sci Immunol. 2025 May 02; 10(107):eadl3852.
PMID: 40315300
Long-term comprehensive cardiopulmonary phenotyping of COVID-19.
Long-term comprehensive cardiopulmonary phenotyping of COVID-19. Respir Res. 2022 Sep 21; 23(1):263.
PMID: 36131349
HIF-1a induces glycolytic reprograming in tissue-resident alveolar macrophages to promote cell survival during acute lung injury.
HIF-1a induces glycolytic reprograming in tissue-resident alveolar macrophages to promote cell survival during acute lung injury. Elife. 2022 07 13; 11.
PMID: 35822617
WITHDRAWN: Update in Critical Care 2021.
WITHDRAWN: Update in Critical Care 2021. Am J Respir Crit Care Med. 2022 04 21.
PMID: 35446238
Identification of a Novel EIF2AK Variant and Genetics-Assisted Approach to Diagnosis of Pulmonary Capillary Hemangiomatosis.
Identification of a Novel EIF2AK Variant and Genetics-Assisted Approach to Diagnosis of Pulmonary Capillary Hemangiomatosis. Lung. 2022 04; 200(2):217-219.
PMID: 35253092
Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension.
Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension. Front Cardiovasc Med. 2021; 8:775039.
PMID: 34950716
Acid Aspiration Impairs Antibacterial Properties of Liver Macrophages.
Acid Aspiration Impairs Antibacterial Properties of Liver Macrophages. Am J Respir Cell Mol Biol. 2021 05; 64(5):641-643.
PMID: 33929292
TGF-ß Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation.
TGF-ß Promotes Metabolic Reprogramming in Lung Fibroblasts via mTORC1-dependent ATF4 Activation. Am J Respir Cell Mol Biol. 2020 11; 63(5):601-612.
PMID: 32668192
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.
IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections. Front Med (Lausanne). 2020; 7:583897.
PMID: 33195334
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections.
IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. medRxiv. 2020 Sep 12.
PMID: 32935118